2019年美国急性缺血性卒中患者特征、护理质量与结局的监测
本研究利用Get With The Guidelines-Stroke登记数据,通过贝叶斯插补后分层抽样权重,生成2019年美国急性缺血性卒中(AIS)的全国评估。估计2019年美国医院共收治552 476例AIS患者,院内死亡率为4.4%,出院时仅52.3%能独立行走。全国AIS绩效指标大多高于95%,但早期卒中就诊者3小时内溶栓使用率为81.9%,其他质量指标如吞咽困难筛查(84.9%)、4.5小时内早期溶栓(79.7%)和他汀治疗(80.6%)较低。
要点
- 2019年美国估计收治552 476例AIS患者,中位年龄71岁,48.8%为女性。
- 合并症:心房颤动22.6%,既往卒中/短暂性脑缺血发作30.2%,糖尿病36.4%。
- 院内死亡率4.4%,出院时仅52.3%能独立行走。
核心结论
- 本研究利用贝叶斯插补后分层抽样权重,提供了及时、可靠且可操作的美国全国AIS监测数据。
- 这些数据可能有助于更有针对性的质量改进、资源分配和全国政策,以改善AIS护理和结局。
研究设计与样本
- 使用Get With The Guidelines-Stroke登记数据,通过贝叶斯插补方法锚定全国住院患者样本的观察值进行加权。
- 将全国住院患者样本的时间趋势估计线性化,以预测2019年美国AIS的住院量、分布和种族/民族特征。
- 主要测量指标包括患者和医院特征、卒中严重程度、生命体征和实验室指标、治疗干预、绩效指标、出院去向和出院临床结局。
主要发现
- 估计2019年美国医院共收治552 476例AIS患者。
- 中位年龄71岁(四分位距60-81),48.8%为女性。
- 心房颤动诊断22.6%,既往卒中/短暂性脑缺血发作30.2%,糖尿病36.4%。
- 基线时46.4%服用抗血小板药,19.2%服用抗凝药,46.3%服用降胆固醇药。
- 院内死亡率4.4%,出院时仅52.3%能独立行走。
关键数值与推荐
- 全国AIS绩效指标大多高于95%,但早期卒中就诊者3小时内溶栓使用率为81.9%。
- 其他质量指标:吞咽困难筛查84.9%,4.5小时内早期溶栓79.7%,他汀治疗80.6%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The United States lacks a timely and accurate nationwide surveillance system for acute ischemic stroke (AIS). We use the Get With The Guidelines-Stroke registry to apply poststratification survey weights to generate national assessment of AIS epidemiology, hospital care quality, and in-hospital outcomes. METHODS: Clinical data from the Get With The Guidelines-Stroke registry were weighted using a Bayesian interpolation method anchored to observations from the national inpatient sample. To generate a US stroke forecast for 2019, we linearized time trend estimates from the national inpatient sample to project anticipated AIS hospital volume, distribution, and race/ethnicity characteristics for the year 2019. Primary measures of AIS epidemiology and clinical care included patient and hospital characteristics, stroke severity, vital and laboratory measures, treatment interventions, performance measures, disposition, and clinical outcomes at discharge. RESULTS: We estimate 552 476 patients with AIS were admitted in 2019 to US hospitals. Median age was 71 (interquartile range, 60-81), 48.8% female. Atrial fibrillation was diagnosed in 22.6%, 30.2% had prior stroke/transient ischemic attack, and 36.4% had diabetes. At baseline, 46.4% of patients with AIS were taking antiplatelet agents, 19.2% anticoagulants, and 46.3% cholesterol-reducers. Mortality was 4.4%, and only 52.3% were able to ambulate independently at discharge. Performance nationally on AIS achievement measures were generally higher than 95% for all measures but the use of thrombolytics within 3 hours of early stroke presentations (81.9%). Additional quality measures had lower rates of receipt: dysphagia screening (84.9%), early thrombolytics by 4.5 hours (79.7%), and statin therapy (80.6%). CONCLUSIONS: We provide timely, reliable, and actionable US national AIS surveillance using Bayesian interpolation poststratification weights. These data may facilitate more targeted quality improvement efforts, resource allocation, and national policies to improve AIS care and outcomes.
引用
- Ziaeian B, Xu H, Matsouaka RA, et al. US Surveillance of Acute Ischemic Stroke Patient Characteristics, Care Quality, and Outcomes for 2019. Stroke. 2022. PMID: 35862201. doi:10.1161/STROKEAHA.122.039098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。